Total submissions: 16
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000163968 | SCV000214568 | likely benign | Hereditary cancer-predisposing syndrome | 2014-12-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000189939 | SCV000243606 | benign | not specified | 2014-07-21 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000234249 | SCV000285433 | benign | Tuberous sclerosis 2 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000189939 | SCV000305237 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000189939 | SCV000341743 | likely benign | not specified | 2016-06-06 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000043272 | SCV000395671 | likely benign | Tuberous sclerosis syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Division of Genomic Medicine, |
RCV000234249 | SCV001430725 | likely benign | Tuberous sclerosis 2 | 2020-07-10 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000234249 | SCV001528545 | uncertain significance | Tuberous sclerosis 2 | 2018-01-18 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Genome- |
RCV000234249 | SCV002040244 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000163968 | SCV002534005 | benign | Hereditary cancer-predisposing syndrome | 2021-03-05 | criteria provided, single submitter | curation | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000189939 | SCV003844220 | benign | not specified | 2023-02-25 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV000234249 | SCV004016142 | benign | Tuberous sclerosis 2 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003390737 | SCV004129878 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | TSC2: BP4, BP7, BS1 |
Color Diagnostics, |
RCV000234249 | SCV004360931 | benign | Tuberous sclerosis 2 | 2022-09-30 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000043272 | SCV004815032 | benign | Tuberous sclerosis syndrome | 2023-12-18 | criteria provided, single submitter | clinical testing | |
Tuberous sclerosis database |
RCV000043272 | SCV000067074 | not provided | Tuberous sclerosis syndrome | no assertion provided | curation |